POSC49 The Cost-Effectiveness of Brentuximab Vedotin in Frontline Systemic Anaplastic Large Cell Lymphoma in France

Autor:	O Chaker, A Nucit, O Salvignol, AC Thoren, H Cranmer, C Coulibaly, J Chevalier, I Borget
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S95
ISSN:	1098-3015
DOI:	10.1016/j.jval.2021.11.454
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f872ff9e9d43c59f977f48fa51dddcd3 https://doi.org/10.1016/j.jval.2021.11.454 Zobrazit plný text záznamu Full Text from ScienceDirect